This suggests that pro-differentiating agents, such as BMPs, may promote a metabolic shift toward oxidative phosphorylation in tumor cells and that BMP2, by decreasing intracellular succinate through induction of SHD activation, may increase PHD2 activity leading to HIF-1α modulation. This evidence concerns the gene BMP2 and neoplasm.